gold investing Comstock Announces Results of Annual General Meeting And Closing of Private Placement Raising Approximately $2.65 Million
MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or Refractory CLL or SLL Previously Treated with a BTK Inhibitor
MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatology
FinEx Metals Announces Exploration Program for its 100%-owned Kero Project in the Central Lapland Greenstone Belt, Finland
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
